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Background: With a paradigm shift toward a chronic care model in cancer, the issue of adherence is becoming
increasingly important in oncology.
Methods: We mailed two self-reported surveys on current nursing practices for patients on oral chemotherapy
to all 309 designated cancer centers and 141 large general hospitals in Japan. The first survey was based on a
nurse-based questionnaire containing 40 items concerning nurse’s characteristics, nurse staffing at workplace,
general nursing care for new patients on oral chemotherapy and those with refilled prescriptions, follow-up, and
system-based approach. The second survey was based on a patient-based questionnaire containing 10 items about
patient characteristics and adherence-related nursing practice for 249 patients taking oral chemotherapy of 903
systematically sampled. We used multivariate logistic regression to identify factors that were associated with
adherence-related nursing practices.
Results: A total of 62 nurses (mean age: 41.5 years) from 62 hospitals who consented participated in the both
nurse-based survey and patient-based survey about 249 patients. The results of nurse-based survey indicated that
practices varied, but nurses were less likely to ask adherence-related questions of patients with refilled prescriptions
than of new patients. The results of patient-based survey found that questions on side effects, discussions about barriers
to achieving balance between treatment and daily life activities, and medication management were all significantly
related to the question about unused medicines. Logistic regression revealed that adherence-related nursing
practices were associated with the nurse’s background, type of treatment, and healthcare system-related factors.
Patient orientation on oral chemotherapy, interdisciplinary learning, and having a system-based approach for
detecting prescription errors were identified as healthcare system-related factors.
Conclusions: A more systematic approach must be developed to ensure patients receive safe and effective oral
chemotherapy, while nurses should play significant roles in patient education and monitoring.
Keywords: Oral chemotherapy, Medication adherence, Compliance, Interdisciplinary care, Medication managementBackground
Recent progress in treatment of cancer has accelerated an
expansion of the development of oral anticancer agents
[1]. The availability of oral anticancer agents has a major
impact on cancer care. In oral chemotherapy, some of the
traditional responsibilities of healthcare providers have
shifted to patients [2]. Despite increased patient’s respon-
sibility for self-management, oral therapy is preferred by
patients mainly because of no need for clinic visits, no
needle placement, and reduced cost [3-5].* Correspondence: hkomatsu@sfc.keio.ac.jp
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unless otherwise stated.As a growing number of patients are choosing oral
chemotherapy over intravenous administration [6], the
issue of adherence is becoming increasingly important in
oncology [7-9]. Traditionally, adherence was not a major
problem in cancer patients compared to other chronic dis-
ease [10] because cancer treatment were usually provided
in acute care settings, and intravenous chemotherapy has
been strictly controlled at outpatient clinic by healthcare
providers. The convenience of oral medication has a flip
side—serious complications and fatal outcomes. Oral
chemotherapy is cost effective, if it is taken as prescribed
[11]. However, if patients are non-adherent to medication,
the cost burden of unused medicines is substantial.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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chaneably, but “adherence” is generally preferred to “com-
pliance” because “compliance” suggests that patient is a
passive follower of the doctor’s orders, and “adherence”
implies that the treatment plan is based on a therapeutic
alliance between the patient and the healthcare provider
[12]. Optimal adherence is achieved “if no doses are
missed, no extra doses are taken, and no doses are taken
in the wrong quantity or at the wrong time” [10]. In gen-
eral, a patient is considered to be adherent if he or she has
taken 80% of a prescribed medication [1].
A number of factors are interrelated with medication
adherence. There are three levels of barriers to adher-
ence: patient, healthcare provider, and healthcare system
levels [12]. The patient-level factors include health be-
liefs and socioeconomic factors, while communication
and the complexity of the regimen are regarded as
healthcare-provider factors [8]. Healthcare system issues
include duration of treatment follow-up visits, prescrib-
ing errors, and conflicting information regarding the
consequences of non-adherence [3].
To overcome barriers to patient adherence, there is no
single standard intervention [13]. However, multidisciplin-
ary and multimodal strategies are considered as effective
[1]. Also, the literature places a primary emphasis on pa-
tient education [4,8,14,15]. Education should be tailored
for individual patients, and patients generally prefer direct
interaction with healthcare providers [4]. Other suggested
interventions include systematic monitoring of patient pill
taking, and use of pill diaries and pill counting [10].
The primary roles of oncology nurses in patients on
oral chemotherapy include patient education, communi-
cation, symptom management, and proactive follow-up
[16]. Their skills help patients with side-effect manage-
ment and handling medications at home, and patient ad-
herence to medication can be improved by follow-up
care [5]. The ASCO/ONS chemotherapy administration
safety standards including oral agents have been estab-
lished in 2013 [7]. A national web-based survey on
current nursing practice patterns for oral chemotherapy
in the United States reported that only half of the nurses
worked in practices with specific policies, procedures,
and resources for patients on oral chemotherapy, and
found erratic procedures and inadequate interdisciplin-
ary communication in many practices [17]. Additional
research is needed to determine the best practice in pa-
tient education, monitoring, and safety management,
and furthermore, to identify the gaps that may exist be-
tween the nurses’ roles and practice [16,17].
We conducted a multicenter cross-sectional question-
naire survey in designated cancer centers and at large
general hospitals in Japan. The goal was to determine a
baseline of nursing practices for oral chemotherapy in
order to improve medication adherence.Methods
Design
A cross-sectional questionnaire survey was designed and
disseminated to 309 cancer centers designated by the
Ministry of Health, Labour and Welfare, and 141 general
hospitals with more than 300 beds in Japan.
Participants and procedures
Designated cancer centers were identified using the list
of healthcare institutions in 2012 from the Ministry of
Health, Labour and Welfare. In November 2012, surveys
were mailed to all 309 designated cancer centers as well
as to 141 general hospitals that were geographically
stratified and randomly selected from all general hospi-
tals with more than 300 beds in Japan. Using systematic
sampling, every 10th patient was selected from a list of
patients who had visited the chemotherapy clinic in par-
ticipating hospitals during the week before the survey.
One nurse, who met the following inclusion criteria,
was selected from each hospital: (1) more than three
years of experience in chemotherapy clinic; (2) experi-
ence as a nursing leader in a chemotherapy clinic; and
(3) willing to participate in the study.
An initial invitation to take part in the survey was sent
to the nursing directors of 450 hospitals. Those who did
not reply received phone calls reminding them about the
survey; those who elected not to participate were ques-
tioned about their reasons. Those who agreed to partici-
pate completed the questionnaires on oral and intravenous
chemotherapy.
Questionnaire
The study consists of two surveys: nurse-based and
patient-based questionnaires. The nurse-based question-
naire developed for this study was based on a previous
study [18] and literature review [4,16,19,20] to determine
nursing practice in patients on oral chemotherapy. It
consists of a total of 40 items concerning nurse’s charac-
teristics such as age, experience of nursing and oral
chemotherapy (8 items), nurse staffing at workplace (4
items), general nursing care for patients who started oral
chemotherapy and those with refilled prescriptions in-
cluding follow-up (20 items), and details of system-based
approach such as interdisciplinary learning opportunities
and prescription error prevention, and prescription error
prevention (8 items). Regarding general nursing care and
system-based approach, the respondents answer ques-
tions “Yes” or “No”.
A 10-item patient-based questionnaire includes demo-
graphic and clinical characteristics of patient (5 items:
age, gender, type of cancer, and primary or recurrent treat-
ment) and “Yes” or “No” questions about adherence-
related nursing practice for individual patients (5 items:
side effects, balance between treatment and daily life
Table 1 Nurse characteristics
Mean SD
Age 41.5 6.4
Years of nursing experience 19.4 6.4
Years of chemotherapy experience 11.6 5.9
Educational Level n %
Junior college and nursing school 56 90.3
≧Bachelor’s degree 6 9.7
Job title
Nurse administrator 5 8.1
Senior charge nurse 27 43.5
Staff nurse 30 48.4




Chemotherapy clinic 49 79.0
Outpatient department 13 21.0
n = 62.
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medication management, and unused medicines). Nurses
in charge at chemotherapy clinics, who replied to the
nurse-based questionnaire, fulfilled this patient-based
questionnaire.
Ethical considerations
The study procedures were approved by the Institutional
Review Board at Keio University (Approval Number: No
198, 2012). In addition, the participating hospitals indi-
vidually obtained study approval if necessary. We ob-
tained informed consent from all participating hospitals,
and anonymity of responses was ensured. We obtained
consent from the nurses and patients.
Statistical analysis
To assess differences between the question on unused
medicine and nursing practices (addressing side effects,
the balance between treatment and daily life, medication
management and monitoring), we used Fisher’s exact
test. A multivariate logistic regression was used to iden-
tify factors associated with adherence-related nursing
practices (the question on unused medicine). Explana-
tory variables were selected for inclusion in the model
using the stepwise selection procedure. The significance
level was set at 0.05.
Results
Of the 450 hospitals providing ambulatory chemother-
apy, 388 declined to participate in the study. Reasons for
non-participation included refusal or non-response of
person in charge (the nursing director forwarded the
questionnaire to the nurse in the chemotherapy clinic
but did not receive a reply) (n = 257), lack of time or
staffing (n = 58), prior participation in other surveys (n =
83), practical difficulties (n = 40), and other (n = 66). A
total of 62 hospitals consented, and 62 nurses in those
hospitals participated in the survey. Of 930 patients who
were systematically sampled, 249 had received oral
chemotherapy. Therefore, 62 nurses fulfilled the patient-
based survey about these 249 patients who those nurses
cared for.
Mean age of the nurse respondents was 41.5 (SD 6.4)
years. Mean years of nursing and chemotherapy experi-
ence were 19.4 (SD 6.4) and 11.6 (SD 5.9), respectively.
Most of the nurses (72.6%) were oncology certified nurses
working at chemotherapy or outpatient clinics (Table 1).
Nurse-based survey
Table 2 shows nurses’ perceptions of nursing processes
for oral chemotherapy. For new patients receiving oral
chemotherapy, more than 90% of nurses reported that
they asked their patients about emergency contacts, side
effects, and family/friend support, and provided patienteducation on medication. In contrast, only 30.6% of nurses
asked whether patients were confident about managing
their medication. Patient understanding (58.1%) and medi-
cation schedule (64.5%) were rated lower than expected.
Nurses were less likely to ask adherence-related questions
of patients with refilled prescriptions than of new patients.
Regarding unused doses of anticancer agents, 35.5% of
nurses reported that they did not confirm the number of
unused doses when patients had refilled prescriptions.
System-based approaches are shown in Table 3. While
40.3% of nurses provided orientation on oral chemother-
apy to patients before initiation of therapy, 32.3% of
hospitals reported offering interdisciplinary learning op-
portunities on oral chemotherapy, and 43.5% had a
system-based approach for detecting prescription errors
of oral anticancer agents. Only one hospital offered a
telephone follow-up for patients on oral chemotherapy.
Patient-based survey
Mean number of chemotherapy patients per day was
23.9 (SD 20.22).
Demographic and clinical characteristics of the 249
chemotherapy patients are presented in Table 4. A com-
bination of intravenous and oral chemotherapy was ad-
ministered to 222 patients (89.2%). More than half of
patients, both male and female, were over 65 years of age.
Gastrointestinal cancer was by far the most common
(69.9%), and 75.4% of treatments were for recurrences.
Table 5 shows the responses of nurses to the questions
on nursing practices related to medication adherence for
the 249 patients on oral chemotherapy. Questions on
Table 2 Nurse-based survey: nurses’ perceptions on nursing processes
Yes No
n % n %
New patients on oral chemotherapy
Medication Schedule
1. Do you confirm the understanding of new patients by letting them explain their medication schedule to you? 40 64.5 22 35.5
Education
2. If the patient does not fully understand the medication protocol, do you give them information about the medication? 58 93.5 4 6.5
Side Effects
3. Do you check whether the patient understands common side effects? 51 82.3 11 17.7
Emergency Contact
4. Do you check whether the patient knows the emergency contact? 56 90.3 6 9.7
Management of Side Effects
5. Do you talk about practical coping methods for side effects with the patient? 58 93.5 4 6.5
Barriers to Adherence (Physical)
6. Do you ask the patient about physical symptoms (e.g., feeling of numbness in hands/legs) as barriers to taking the medication? 56 90.3 6 9.7
Patient Confidence in Medication Management
7. Do you ask the patient how confident they are about managing their medication? 19 30.6 43 69.4
Balance Between Treatment and Daily Life Activities
8. Do you talk to the patient about potential barriers to achieving balance between treatment and daily activities? 39 62.9 23 37.1
Support
9. Do you offer support to the patient to encourage him/her or to ease anxiety? 58 93.5 4 6.5
Family/Friend Support
10. Do you ask the patient whether he/she has a supportive family/friend? 58 93.5 4 6.5
Financial Burden
11. Do you ask the patient whether he/she feels financially burdened? 43 69.4 19 30.6
Social Resources
12. Do you provide information on social resources to the patient if financial problems are a barrier to treatment? 53 85.5 9 14.5
Patient Understanding
13. Do you ask the patient about his/her understanding of oral chemotherapy (e.g., effectiveness and preference)? 36 58.1 26 41.9
Patients with Refilled Prescriptions
Patient's Knowledge
1. Do you ask the patient about how he/she currently manages his/her medication schedule? 44 71.0 18 29.0
Skipping
2. Do you ask the patient whether he/she ever skips a dose of his/her oral anticancer medication? 55 88.7 7 11.3
Non-compliance
3. Do you ask the patient whether he/she has unused medicines? 40 64.5 22 35.5
Reasons for Non-compliance
4. Do you ask the patient about his/her reasons for not following the physician's instructions? 52 83.9 10 16.1
Support for Resolution
5. Do you talk about problem-solving methods in regards to medication management? 46 74.2 16 25.8
Report of Skipping to Healthcare Professionals
6. Do you ask the patient whether he/she tells his/her healthcare providers when he/she skips a dose of medicine? 48 77.4 14 22.6
Support for Management of Side Effects
7. Do you provide the patient with further advice about coping methods for side effects? 47 75.8 15 24.2
(n=62).
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Table 3 Nurse-based survey: system-based approach
Yes No
n % n %
Patient Orientation
1. Do you provide orientation to new patients on oral chemotherapy? 25 40.3 37 59.7
Telephone Follow-up
2. Is it routine to follow up with patients by telephone after they have received their first course of oral chemotherapy? 1 1.6 61 98.4
Emergency Contact
3. Are patients on oral chemotherapy given an emergency contact number (including for nights/holidays)? 55 88.7 7 11.3
Patient Consultation and Education
4. Is there any process in place to provide consultation and education to patients on oral chemotherapy? 28 45.2 34 54.8
Education for Emergency Nurses
5. Does your institution offer learning opportunities for nurses who provide care for patients on oral chemotherapy in the
emergency department?
7 11.3 55 88.7
Collaboration Between Chemotherapy and Emergency Nurses
6. Is there any collaboration system in place for the sharing of information on a patient’s emergency visit between chemotherapy
and emergency nurses?
15 24.2 47 75.8
Interdisciplinary Learning
7. Do you have any interdisciplinary learning opportunities regarding oral chemotherapy? 20 32.3 42 67.7
System-based Approach for Detecting Prescription Errors
8. Is there any system-based approach for detecting prescription errors? 27 43.5 35 56.5
n=62.









Breast cancer 30 12.0
Gastrointestinal cancer 174 69.9
Lung cancer 16 6.4
Others (e.g., hematological, uterine and ovary cancer) 26 10.4
Unknown 3 1.2
Purpose of Treatment
Primary treatment 61 24.5
Recurrence treatment 188 75.5
Type of Treatment
Combination of oral and intravenous chemotherapy 222 89.2
Only oral chemotherapy 22 8.8
Unknown 5 2.0
n=249.
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ance between treatment and daily life activities, and
medication management were all significantly related to
the question about unused medicines.
Factors predicting adherence-related nursing practices
Given that the question on unused medicines could be
used as a kind of proxy for adherence-related nursing prac-
tices, a multivariable logistic regression model was created.
The results of the logistic regression analysis are shown in
Table 6. Nurses’ experience, education and qualifications,
the combination of oral and intravenous treatment, patient
orientation on oral chemotherapy, interdisciplinary learn-
ing, and having a system-based approach for detecting
prescription errors remained significant. The factors ex-
plained 40.3% of the variance in the model.
Discussion
This is the first report on current nursing practices for
patients receiving oral chemotherapy in Japan. There
was great variation in practices across the nation. The
survey results demonstrated that a majority of the can-
cer centers and large hospitals in Japan are responding
to the emerging needs of oral chemotherapy in conven-
tional care systems, with only a minority incorporating
systems specific to oral chemotherapy. Adherence-
related nursing practices were associated with the nurse’s
background, the type of treatment, and healthcare
system-related factors.
Table 5 Patient-based survey: unused medicines and other adherence-related questions (n = 249)
Asking about unused medicines
P value
Yes No
Do you talk about side effects with the patient? Yes 214 (85.9%) 108 (98.2%) 106 (76.3%)
<0.001
No 35 (14.1%) 2 (1.8%) 33 (23.3%)
Do you talk about barriers to balance between treatment and daily
life activities with the patient?
Yes 181 (72.7%) 101 (91.8%) 80 (57.6%)
<0.001
No 68 (27.3%) 9 (13.2%) 59 (42.4%)
Do you think that this patient manages his/her medication
(oral chemotherapy) at home?
Yes 230 (92.4%) 105 (95.5%) 125 (89.9%)
0.148
No 19 (7.6%) 5 (4.5%) 14 (10.2%)
Do you think that monitoring medication management (oral chemotherapy)
for this patient is your role?
Yes 202 (81.1%) 104 (94.5%) 98 (70.5%)
<0.001
No 47 (18.9%) 6 (5.5%) 41 (29.5%)
Fisher’s exact test.
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ing the medication management of patients receiving
oral chemotherapy. In the present study, nearly 20% of
nurses were not aware of their monitoring role. Al-
though nurses educate patients about intravenous
chemotherapy, few are involved in oral chemotherapy
[5]. As understanding the clinical importance of oral
chemotherapy is reported to encourage adherence in
90% of patients [3], patient should be made well aware
of both the benefits of medication and the risks of non-
adherence [14]. Patient education is the cornerstone of
successful oral chemotherapy [8,15]. A feasibility pilot
study of new medication adherence interventions suggests
that nurses have an important role to play in education,
monitoring, and follow-up [21]. A strong patient-nurse re-
lationship is fundamental to individualized education,Table 6 Factors predicting adherence-related nursing
practices by logistic regression
Odds ratio (95% CI) p-value
Nurse factor
Years of experience 1 - .008
6-10 (years) 4.209 (1.240 - 14.284) .021
<10 1.028 (0.320 - 3.300) .963
Education University .016 (0.003 - 0.073) <.001
Oncology certified nurse 5.786 (2.337 - 14.324) <.001
Patient factor
Oral + IV combination therapy .240 (0.070 - 0.828) .024
System factor
Patient orientation 3.348 (1.633 - 6.861) .001
Interdisciplinary learning 2.997 (1.469 - 6.114) .003
System-based approach for
detecting prescription errors
3.671 (1.865 - 7.226) <.001
Note. CI = confidence interval.
Variables entered: years of experience, education, certification; age, type of
cancer, regimen; patient orientation, telephone follow-up, emergency contact,
patient consultation and education, and education for emergency nurse,
interdisciplinary, and system-based approach for detecting prescription errors.leading to successful management of and adherence to
treatment regimens [4].
The nurses were unlikely to ask how patients under-
stood the therapy and how they managed medication at
home, and very few nurses asked whether patients were
confident in medication management. Patients may not
be confident in medication management, but nurses do
not know how they feel about isolation. At least, nurses
should ask patients whether they are taking their medi-
cation as prescribed. Information the nurse could gain
from this simple question is worth to ask. The answer
implies patient adherence to medication. Recently,
nurses’ contact with patients is decreasing [18]. It is be-
cause oral chemotherapy is often administered outside
of controlled settings [7], and patients usually receive
medication information directly from the oncologist or
pharmacist without nursing support [16]. Regular con-
tact with a single nurse helps promote patients’ trust
[22], and facilitates identification of concerns about
treatment and daily life activities. The patient-nurse rela-
tionship and collaboration of the healthcare team are
essential components of patient adherence [23]. A pro-
active attitude on the part of the nurse is a key in caring
for patients on oral chemotherapy.
Healthcare-system related factors were predictors of
adherence-related nursing practices in this study. Such
factors included patient orientation with an overview of
oral chemotherapy presented by a nurse, interdisciplin-
ary learning opportunities, and a system-based approach
for detecting prescription errors. As oral chemotherapy
becomes more common, more patients will require edu-
cation. Patient orientation for oral chemotherapy should
be systematically implemented for every patient who initi-
ates this type of therapy. Patient education about the dis-
ease, treatment, and symptom management is the role of
the oncology nurse [24], and staffing for orientation is im-
portant to ensure patients receive the necessary education.
Currently, healthcare providers have little ability to
directly manage oral chemotherapy care [25]. There is
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ciplinary team among healthcare providers in cancer
care [26]. Interdisciplinary learning opportunities remind
team members of their roles, integrate professional
knowledge, and facilitate collective work [27].
Regarding prescription errors, intravenous chemother-
apy is commonly double-checked or triple-checked by
multiple staff in controlled settings. The safety issues in
oral chemotherapy are just important as those in intra-
venous chemotherapy [2], however, the safe delivery of
oral chemotherapy may depend on the competency of
those dispensing the medication [7]. Including a set rou-
tine in an organization’s safety infrastructure can raise
the awareness of healthcare providers on safety and
monitoring of administration of oral anticancer agents.
Institutional safety infrastructure is critical for favourable
clinical outcomes [15].
In the present study, nurses asked about adherence to
medication regimens more frequently when patients
were on oral chemotherapy alone, rather than on com-
bined intravenous and oral chemotherapy. This may
have been in part because nurses must focus on strict
standards in administering intravenous chemotherapy,
and therefore might not have the time to ask about oral
medication. Adherence is not only an issue for patients
new to oral chemotherapy, but also for those with
refilled prescriptions [28]. As shown in the results of the
present study, nurses are less likely to monitor medica-
tions of patients with refilled prescriptions. Cancer
patients tend to undergo long-term treatment, and
therefore the concept of follow-up, keeping track of the
condition of cancer patients, is important. Shared ac-
countability among multiple providers in cancer care
makes individual accountability blur. In addition to indi-
vidual commitment to care, major improvement requires
coherent strategies of the organization.
There are a number of limitations to the present study.
Systematic sampling is vulnerable to periodicities which
might lead to bias. Very few hospitals approved the sur-
vey because of strict regulations on patient data. We
confirmed that all hospitals received invitations to par-
ticipate in the survey, but could not reach the person in
charge at all the hospitals we approached. Thus, low re-
sponse rate may have produced a bias if the replies from
respondents were not representative of the national sam-
ple. The present study relied on the nurses’ response to
the questionnaires. We did not measure actual patient
adherence to medication regimens. This survey focused
on chemotherapy clinics; outpatient and primary care
settings were not included. Therefore, the results of the
survey do not reflect the overall picture of oral chemo-
therapy treatment. The results of the logistic regression
suggested that nurses with higher education were unlikely
to ask about unused medicines, which is difficult toexplain; however, there were only 6 nurses who had edu-
cational backgrounds higher than university. This small
number might have produced the unexpected result.
Conclusions
A multicenter cross-sectional survey revealed that
adherence-related nursing practices were associated with
the nurse’s background, type of treatment, and health-
care system-related factors, including patient orientation
on oral chemotherapy, interdisciplinary learning, and hav-
ing a system-based approach for detecting prescription er-
rors. With the increase of oral chemotherapy, a new
model of patient care is required. A more systematic ap-
proach should be developed to ensure patients receive safe
and effective oral chemotherapy, while nurses should play
significant roles in patient education and monitoring.
Further studies are needed to develop an organized
system of care in which nurses proactively support pa-
tients in managing safe and effective oral chemotherapy
and improve medication adherence with coordination
among healthcare providers.
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